IP Library Patent Application 18065369
Patent Application
App. No. 18/065,369

COMPOSITIONS TO DETECT ADENOVIRUS NUCLEIC ACIDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/065,369
Abstract

The disclosed invention is related to methods, compositions, kits and isolated nucleic acid sequences for targeting Adenovirus nucleic acid. Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one of these oligomers.

Claims (37)

1 . A composition comprising a detection probe configured to hybridize to a portion of an Adenovirus nucleic acid or to a portion of an amplicon generated therefrom, wherein the detection probe comprises

(a) a target hybridizing sequence selected from the group consisting of SEQ ID NO:10, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:36, SEQ ID NO:37, SEQ ID NO:39 and SEQ ID NO:40; and

(b) one or more of

(i) a label,

(ii) a substitution at the 2′ position of at least one ribose moiety, and

(iii) a blocking moiety at or near the 3′ end of the detection probe, wherein the blocking moiety is configured to prevent enzyme-mediated extension of the detection probe in an amplification reaction.

2 . The composition of claim 1 , wherein the detection probe comprises the label and the label is selected from the group consisting of a fluorescent label, a chemiluminescent label, a radiolabel, an enzyme label, a hapten label, a linked oligonucleotide label, or an electronically detectable label.

3 . The composition of claim 1 , wherein the detection probe comprises an interactive pair of labels.

4 . The composition of claim 3 , wherein the interactive pair of labels is a fluorescent label in combination with a quencher.

5 . The composition of claim 3 , wherein the detection probe is a hairpin probe.

6 . The composition of claim 5 , wherein the hairpin probe is a molecular torch or a molecular beacon.

7 . A composition comprising at least two detection probes configured to hybridize to a portion of an Adenovirus nucleic acid or to a portion of an amplicon generated therefrom, wherein each of the detection probes comprises

(a) a target hybridizing sequence selected from the group consisting of SEQ ID NO:10, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:36, SEQ ID NO:37, SEQ ID NO:39 and SEQ ID NO:40; and

(b) one or more of

(i) a label,

(ii) a substitution at the 2′ position of at least one ribose moiety, and

(iii) a blocking moiety at or near the 3′ end of the detection probe, wherein the blocking moiety is configured to prevent enzyme-mediated extension of the detection probe in an amplification reaction.

8 . The composition of claim 7 , wherein each of the at least two detection probes comprises the label and the label is selected from the group consisting of a fluorescent label, a chemiluminescent label, a radiolabel, an enzyme label, a hapten label, a linked oligonucleotide label, or an electronically detectable label.

9 . The composition of claim 7 , wherein each of the at least two detection probes comprises an interactive pair of labels.

10 . The composition of claim 9 , wherein the interactive pair of labels is a fluorescent label in combination with a quencher.

11 . The composition of claim 9 , wherein each of the at least two detection probes is a hairpin probe.

12 . The composition of claim 11 , wherein the hairpin probe is a molecular torch or a molecular beacon.

13 . A hybridization assay reaction mixture comprising:

(1) a detection probe configured to hybridize to a portion of an Adenovirus nucleic acid or to a portion of an amplicon generated therefrom, wherein the detection probe comprises

(a) a target hybridizing sequence selected from the group consisting of SEQ ID NO:10, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:36, SEQ ID NO:37, SEQ ID NO:39 and SEQ ID NO:40; and

(b) one or more of

(i) a label,

(ii) a substitution at the 2′ position of at least one ribose moiety, and

(iii) a blocking moiety at or near the 3′ end of the detection probe, wherein the blocking moiety is configured to prevent enzyme-mediated extension of the detection probe in an amplification reaction; and

(2) a salt.

14 . The reaction mixture of claim 13 , wherein the detection probe comprises the label and the label is a homogeneous detectable label.

15 . The reaction mixture of claim 14 , wherein the homogeneous detectable label is a fluorescent label, a chemiluminescent label, or an electronically detectable label.

16 . The reaction mixture of claim 13 , wherein the detection probe comprises an interactive pair of labels.

17 . The reaction mixture of claim 16 , wherein the interactive pair of labels is a fluorescent label in combination with a quencher.

18 . The reaction mixture of claim 16 , wherein the detection probe is a hairpin probe.

19 . The reaction mixture of claim 18 , wherein the hairpin probe is a molecular torch or a molecular beacon.

20 . The reaction mixture of claim 13 , wherein the salt is selected from the group consisting of lithium chloride, sodium chloride, and sodium citrate.

Assignments (4)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 065286/0407 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE PRODESSE, INC.
Reel/Frame 075457/0767 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2024
From: ZIEGLER, EMILY; TOWNSEND, JESSICA
To: GEN-PROBE PRODESSE INC. C/O GEN-PROBE INCORPORATED
Reel/Frame 066860/0373 →
SECURITY INTEREST Recorded Oct 19, 2023
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 065286/0407 →